Fractal analysis of two-dimensional vascularity in primary prostate cancer and surrounding non-tumoral parenchyma
- 15 July 2009
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 205 (7) , 438-444
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Prostate cancer: the new evidence base for diagnosis and treatmentPathology, 2007
- Molecular markers and mortality in prostate cancerBJU International, 2007
- Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trialsEuropean Journal of Cancer, 2006
- Prognostic factors in prostate cancerDiagnostic Pathology, 2006
- Gleason Scoring Varies Among Pathologists and this Affects Clinical Risk in Patients with Prostate CancerClinical Oncology, 2005
- The Use of Genetic Markers to Determine Risk for Prostate Cancer at Prostate BiopsyClinical Cancer Research, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Angiogenesis in health and diseaseNature Medicine, 2003
- Clinical Application of Antiangiogenic Therapy: Microvessel Density, What It Does and Doesn't Tell UsJNCI: Journal of the National Cancer Institute, 2002
- Prostate-specific antigen: current statusCA: A Cancer Journal for Clinicians, 1999